Finanzdaten der Bio Rad Laboratories Inc-Aktie (BIO)
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues | 0.83%656.40 | 651.00 | 592.10 | 693.20 | 653.00 |
| Cost Of Revenue | 7.40%327.80 | 305.20 | 282.70 | 348.00 | 309.60 |
| Gross Profit | 4.97%328.60 | 345.80 | 309.40 | 345.20 | 343.40 |
21.27%257.10 | 212.00 | 212.40 | 221.00 | 206.80 | |
| Selling, General, and Administrative | 21.27%257.10 | 212.00 | 212.40 | 221.00 | 206.80 |
| Research and Development | 16.67%71.40 | 61.20 | 62.90 | 70.30 | 71.30 |
| Interest Income/Expense | 1.65%12.30 | 12.10 | 12.30 | 12.10 | 12.30 |
| Operating Income/Loss | 168.46%-49.70 | 72.60 | 34.10 | -118.90 | 65.30 |
| Income/Loss From Continuing Operations Before Tax | 0.63%538.70 | 542.10 | -689.80 | 929.20 | -431.10 |
| Income Tax Expense/Benefit | 53.08%80.10 | 170.70 | -162.70 | 209.20 | -89.20 |
23.48%458.60 | 371.40 | -527.10 | 720.00 | -341.90 | |
| Attributable To Parent | 23.48%458.60 | 371.40 | -527.10 | 720.00 | -341.90 |
| Basic Average Shares | 0.13%26.78 | 26.75 | 26.96 | - | 26.92 |
| Diluted Average Shares | 0.49%26.95 | 26.81 | 26.96 | - | 26.92 |
| Basic Earnings Per Share | 23.33%17.13 | 13.89 | -19.55 | - | -12.70 |
| Diluted Earnings Per Share | 22.89%17.02 | 13.85 | -19.55 | - | -12.70 |